ANAGRELIDE-INDUCED PERICARDIAL EFFUSION IN A PATIENT WITH ESSENTIAL
THROMBOCYTHEMIA
- David Song,
- Jawad Shabani,
- Vikash Jaiswal
, - Kusum Paudel,
- Arjun Gupta,
- David Rubinstein
Abstract
We present a rare case of anagrelide-induced pericardial effusion that
is presented with tamponade physiology in a patient with essential
thrombocythemia. After cautiously weighing the risks and benefits of
further invasive interventions following an unsuccessful
pericardiocentesis, the decision was to stop anagrelide while managing
the pericardial effusion medically.13 Dec 2022Submitted to Clinical Case Reports 14 Dec 2022Submission Checks Completed
14 Dec 2022Assigned to Editor
16 Dec 2022Reviewer(s) Assigned
29 Jan 2023Review(s) Completed, Editorial Evaluation Pending
02 Feb 2023Editorial Decision: Revise Major
26 Feb 20231st Revision Received
15 Mar 2023Assigned to Editor
15 Mar 2023Submission Checks Completed
15 Mar 2023Review(s) Completed, Editorial Evaluation Pending
16 Mar 2023Reviewer(s) Assigned
22 Mar 2023Editorial Decision: Revise Minor
29 Mar 20232nd Revision Received
30 Mar 2023Assigned to Editor
30 Mar 2023Submission Checks Completed
30 Mar 2023Review(s) Completed, Editorial Evaluation Pending
07 Apr 2023Editorial Decision: Accept
